-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on Castle Biosciences, Raises Price Target to $52

Benzinga·01/12/2026 15:17:02
Listen to the news
Lake Street analyst Thomas Flaten maintains Castle Biosciences (NASDAQ:CSTL) with a Buy and raises the price target from $35 to $52.